메뉴 건너뛰기




Volumn 6, Issue , 2016, Pages

Combinations of oseltamivir and T-705 extend the treatment window for highly pathogenic influenza a (H5N1) virus infection in mice

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; FAVIPIRAVIR; OSELTAMIVIR; PYRAZINE DERIVATIVE;

EID: 84971228935     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26742     Document Type: Article
Times cited : (45)

References (62)
  • 2
    • 28044445881 scopus 로고    scopus 로고
    • Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells
    • doi: 10.1186/1465-9921-6-135
    • Chan, M. C., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6, 135, doi: 10.1186/1465-9921-6-135 (2005).
    • (2005) Respir Res , vol.6 , pp. 135
    • Chan, M.C.1
  • 3
    • 33749511112 scopus 로고    scopus 로고
    • Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
    • doi: 10.1038/nm1477
    • de Jong, M. D., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12, 1203-1207, doi: 10.1038/nm1477 (2006).
    • (2006) Nat Med , vol.12 , pp. 1203-1207
    • De Jong, M.D.1
  • 4
    • 84927919568 scopus 로고    scopus 로고
    • Genesis of avian influenza H9N2 in Bangladesh
    • doi: 10.1038/emi.2014.84
    • Shanmuganatham, K., et al. Genesis of avian influenza H9N2 in Bangladesh. Emerg Microbes Infect 3, e88, doi: 10.1038/emi.2014.84 (2014).
    • (2014) Emerg Microbes Infect , vol.3 , pp. e88
    • Shanmuganatham, K.1
  • 5
    • 84933579614 scopus 로고    scopus 로고
    • Differences in the epidemiology of human cases of avian influenza a(h7n9) and a(h5n1) viruses infection
    • doi: 10.1093/cid/civ345
    • Qin, Y., et al. Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. Clin Infect Dis, doi: 10.1093/cid/civ345 (2015).
    • (2015) Clin Infect Dis
    • Qin, Y.1
  • 6
    • 84911979789 scopus 로고    scopus 로고
    • A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China
    • doi: 10.1111/irv.12289
    • Fan, S., et al. A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China. Influenza Other Respir Viruses 8, 646-653, doi: 10.1111/irv.12289 (2014).
    • (2014) Influenza Other Respir Viruses , vol.8 , pp. 646-653
    • Fan, S.1
  • 7
    • 84929591129 scopus 로고    scopus 로고
    • Intercontinental spread of asian-origin h5n8 to North America through beringia by migratory birds
    • doi: 10.1128/JVI.00728-15
    • Lee, D. H., et al. Intercontinental Spread of Asian-Origin H5N8 to North America through Beringia by Migratory Birds. J Virol 89, 6521-6524, doi: 10.1128/JVI.00728-15 (2015).
    • (2015) J Virol , vol.89 , pp. 6521-6524
    • Lee, D.H.1
  • 8
    • 84922326721 scopus 로고    scopus 로고
    • Heterologous prime-boost vaccination using an AS03B-Adjuvanted influenza A(H5N1) vaccine in infants and children < 3 years of age
    • doi: 10.1093/infdis/jiu359
    • Nolan, T., et al. Heterologous prime-boost vaccination using an AS03B-Adjuvanted influenza A(H5N1) vaccine in infants and children
    • (2014) The Journal of Infectious Diseases , vol.210 , pp. 1800-1810
    • Nolan, T.1
  • 9
    • 77954632352 scopus 로고    scopus 로고
    • News releaseAvailable at (Accessed: 9th March2016
    • U.S. Food and Drug Administration. News release (2013). Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376444.htm (Accessed: 9th March 2016).
    • (2013) US Food and Drug Administration
  • 11
    • 84922726229 scopus 로고    scopus 로고
    • Antiviral combinations for severe influenza
    • doi: 10.1016/S1473-3099(14)70821-7
    • Dunning, J., et al. Antiviral combinations for severe influenza. The Lancet. Infectious diseases 14, 1259-1270, doi: 10.1016/S1473-3099(14)70821-7 (2014).
    • (2014) The Lancet. Infectious Diseases , vol.14 , pp. 1259-1270
    • Dunning, J.1
  • 12
    • 84904746307 scopus 로고    scopus 로고
    • Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-Therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
    • doi: 10.1016/S1473-3099(14)70736-4
    • Cahn, P., et al. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-Therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial. The Lancet. Infectious diseases 14, 572-580, doi: 10.1016/S1473-3099(14)70736-4 (2014).
    • (2014) The Lancet. Infectious Diseases , vol.14 , pp. 572-580
    • Cahn, P.1
  • 13
    • 21244447705 scopus 로고    scopus 로고
    • Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    • doi: 10.1056/NEJMoa043470
    • Lau, G K., et Al. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-positive Chronic Hepatitis B. the New England Journal of Medicine 352, 2682-2695, Doi: 10.1056/NEJMoa043470 (2005).
    • (2005) The New England journal of medicine , vol.352 , pp. 2682-2695
    • Lau, G.K.1
  • 14
    • 84929513365 scopus 로고    scopus 로고
    • Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: An open-label, randomised, phase 3 trial
    • doi: 10.1016/S1473-3099(15)70099-X
    • Mizokami, M., et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. The Lancet. Infectious diseases 15, 645-653, doi: 10.1016/S1473-3099(15)70099-X (2015).
    • (2015) The Lancet. Infectious Diseases , vol.15 , pp. 645-653
    • Mizokami, M.1
  • 15
    • 78650232558 scopus 로고    scopus 로고
    • Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model
    • doi: 10.1016/j.antiviral.2010.09.020
    • Bantia, S., Kellogg, D., Parker, C. D., & Babu, Y. S. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model. Antiviral Res 88, 276-280, doi: 10.1016/j.antiviral.2010.09.020 (2010).
    • (2010) Antiviral Res , vol.88 , pp. 276-280
    • Bantia, S.1    Kellogg, D.2    Parker, C.D.3    Babu, Y.S.4
  • 16
    • 9644262504 scopus 로고    scopus 로고
    • Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
    • doi: 10.1128/AAC.48.12.4855-4863.2004
    • Govorkova, E. A., Fang, H. B., Tan, M., & Webster, R. G. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrobial agents and chemotherapy 48, 4855-4863, doi: 10.1128/AAC.48.12.4855-4863.2004 (2004).
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , pp. 4855-4863
    • Govorkova, E.A.1    Fang, H.B.2    Tan, M.3    Webster, R.G.4
  • 17
    • 34249001427 scopus 로고    scopus 로고
    • Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice
    • Ilyushina, N. A., Hoffmann, E., Salomon, R., Webster, R. G., & Govorkova, E. A. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther 12, 363-370 (2007).
    • (2007) Antivir Ther , vol.12 , pp. 363-370
    • Ilyushina, N.A.1    Hoffmann, E.2    Salomon, R.3    Webster, R.G.4    Govorkova, E.A.5
  • 18
    • 0028932874 scopus 로고
    • In vitro inhibitory effects of combinations of anti-influenza agents
    • Madren, L. K., Shipman, Jr. C., & Hayden, F. G. In vitro inhibitory effects of combinations of anti-influenza agents. Antiviral Chemistry & Chemotherapy 2, 109-113 (1995).
    • (1995) Antiviral Chemistry & Chemotherapy , vol.2 , pp. 109-113
    • Madren, L.K.1    Shipman, C.2    Hayden, F.G.3
  • 19
    • 0042656406 scopus 로고    scopus 로고
    • Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza
    • Ison, M. G., et al. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther 8, 183-190 (2003).
    • (2003) Antivir Ther , vol.8 , pp. 183-190
    • Ison, M.G.1
  • 21
    • 76249125006 scopus 로고    scopus 로고
    • T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
    • doi: 10.1073/pnas.0909603107
    • Kiso, M., et al. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci USA 107, 882-887, doi: 10.1073/pnas.0909603107 (2010).
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 882-887
    • Kiso, M.1
  • 22
    • 84885660826 scopus 로고    scopus 로고
    • Characterization of H7N9 influenza A viruses isolated from humans
    • doi: 10.1038/nature12392
    • Watanabe, T., et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551-555, doi: 10.1038/nature12392 (2013).
    • (2013) Nature , vol.501 , pp. 551-555
    • Watanabe, T.1
  • 23
    • 73849083795 scopus 로고    scopus 로고
    • Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice
    • doi: 10.1128/AAC.00933-09
    • Smee, D. F., et al. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice. Antimicrobial agents and chemotherapy 54, 126-133, doi: 10.1128/AAC.00933-09 (2010).
    • (2010) Antimicrobial Agents and Chemotherapy , vol.54 , pp. 126-133
    • Smee, D.F.1
  • 25
    • 84885448756 scopus 로고    scopus 로고
    • Favipiravir (T-705), a novel viral RNA polymerase inhibitor
    • doi: 10.1016/j. antiviral.2013.09.015
    • Furuta, Y., et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 100, 446-454, doi: 10.1016/j. antiviral.2013.09.015 (2013).
    • (2013) Antiviral Res , vol.100 , pp. 446-454
    • Furuta, Y.1
  • 26
    • 68849100983 scopus 로고    scopus 로고
    • Severe respiratory disease concurrent with the circulation of H1N1 influenza
    • doi: 10.1056/NEJMoa0904023
    • Chowell, G., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. The New England journal of medicine 361, 674-679, doi: 10.1056/NEJMoa0904023 (2009).
    • (2009) The New England Journal of Medicine , vol.361 , pp. 674-679
    • Chowell, G.1
  • 27
    • 50149111585 scopus 로고    scopus 로고
    • Factors associated with case fatality of human H5N1 virus infections in Indonesia: A case series
    • doi: 10.1016/S0140-6736(08)61125-3
    • Kandun, I. N., et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 372, 744-749, doi: 10.1016/S0140-6736(08)61125-3 (2008).
    • (2008) Lancet , vol.372 , pp. 744-749
    • Kandun, I.N.1
  • 28
    • 69149095237 scopus 로고    scopus 로고
    • Viral loads and duration of viral shedding in adult patients hospitalized with influenza
    • doi: 10.1086/600383
    • Lee, N., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. The Journal of infectious diseases 200, 492-500, doi: 10.1086/600383 (2009).
    • (2009) The Journal of Infectious Diseases , vol.200 , pp. 492-500
    • Lee, N.1
  • 29
    • 68149107226 scopus 로고    scopus 로고
    • Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico
    • doi: 10.1056/NEJMoa0904252
    • Perez-Padilla, R., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. The New England journal of medicine 361, 680-689, doi: 10.1056/NEJMoa0904252 (2009).
    • (2009) The New England Journal of Medicine , vol.361 , pp. 680-689
    • Perez-Padilla, R.1
  • 30
    • 38349068756 scopus 로고    scopus 로고
    • Update on avian influenza A (H5N1) virus infection in humans
    • Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza, A. V., et al. doi: 10.1056/NEJMra0707279
    • Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza, A. V., et al. Update on avian influenza A (H5N1) virus infection in humans. The New England journal of medicine 358, 261-273, doi: 10.1056/NEJMra0707279 (2008).
    • (2008) The New England Journal of Medicine , vol.358 , pp. 261-273
  • 31
    • 77954981636 scopus 로고    scopus 로고
    • Competitive fitness of oseltamivir-sensitive and-resistant highly pathogenic H5N1 influenza viruses in a ferret model
    • doi: 10.1128/JVI.00689-10
    • Govorkova, E. A., Ilyushina, N. A., Marathe, B. M., McClaren, J. L., & Webster, R. G. Competitive fitness of oseltamivir-sensitive and-resistant highly pathogenic H5N1 influenza viruses in a ferret model. J Virol 84, 8042-8050, doi: 10.1128/JVI.00689-10 (2010).
    • (2010) J Virol , vol.84 , pp. 8042-8050
    • Govorkova, E.A.1    Ilyushina, N.A.2    Marathe, B.M.3    McClaren, J.L.4    Webster, R.G.5
  • 32
    • 84875107202 scopus 로고    scopus 로고
    • T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro
    • doi: 10.1128/JVI.02346-12
    • Baranovich, T., et al. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol 87, 3741-3751, doi: 10.1128/JVI.02346-12 (2013).
    • (2013) J Virol , vol.87 , pp. 3741-3751
    • Baranovich, T.1
  • 33
    • 70349272201 scopus 로고    scopus 로고
    • Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses
    • doi: 10.1128/JVI.01109-09
    • Zhou, B., et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83, 10309-10313, doi: 10.1128/JVI.01109-09 (2009).
    • (2009) J Virol , vol.83 , pp. 10309-10313
    • Zhou, B.1
  • 34
    • 84929999966 scopus 로고    scopus 로고
    • Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection
    • doi: 10.1128/mBio.02464-14
    • Rogers, M. B., et al. Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection. MBio 6, doi: 10.1128/mBio.02464-14 (2015).
    • (2015) MBio , vol.6
    • Rogers, M.B.1
  • 35
    • 84926647098 scopus 로고    scopus 로고
    • Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck
    • doi: 10.1038/ncomms7553
    • Zaraket, H., et al. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat Commun 6, 6553, doi: 10.1038/ncomms7553 (2015).
    • (2015) Nat Commun , vol.6 , pp. 6553
    • Zaraket, H.1
  • 36
    • 84921260778 scopus 로고    scopus 로고
    • Similar prevalence of low-Abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PloS one 9, e105569
    • doi: 10.1371/0105569
    • Margeridon-Thermet, S., et al. Similar prevalence of low-Abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PloS one 9, e105569, doi: 10.1371/journal.pone.0105569 (2014).
    • (2014) Journal.pone.
    • Margeridon-Thermet, S.1
  • 37
    • 84859878103 scopus 로고    scopus 로고
    • Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing
    • doi: 10.1371/journal.pone.0035052
    • Nishijima, N., et al. Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing. PloS one 7, e35052, doi: 10.1371/journal.pone.0035052 (2012).
    • (2012) PloS One , vol.7 , pp. e35052
    • Nishijima, N.1
  • 38
    • 84875994350 scopus 로고    scopus 로고
    • A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model
    • doi: 10.1016/j.antiviral.2013.03.007
    • Ramirez, C., et al. A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res 98, 273-283, doi: 10.1016/j.antiviral.2013.03.007 (2013).
    • (2013) Antiviral Res , vol.98 , pp. 273-283
    • Ramirez, C.1
  • 39
    • 84885907998 scopus 로고    scopus 로고
    • Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase
    • doi: 10.1128/AAC.00649-13
    • Sangawa, H., et al. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrobial agents and chemotherapy 57, 5202-5208, doi: 10.1128/AAC.00649-13 (2013).
    • (2013) Antimicrobial Agents and Chemotherapy , vol.57 , pp. 5202-5208
    • Sangawa, H.1
  • 40
    • 14744274674 scopus 로고    scopus 로고
    • Mechanism of action of T-705 against influenza virus
    • doi: 10.1128/AAC.49.3.981-986.2005
    • Furuta, Y., et al. Mechanism of action of T-705 against influenza virus. Antimicrobial agents and chemotherapy 49, 981-986, doi: 10.1128/AAC.49.3.981-986.2005 (2005).
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , pp. 981-986
    • Furuta, Y.1
  • 41
    • 25444501243 scopus 로고    scopus 로고
    • Neuraminidase inhibitors for influenza
    • doi: 10.1056/NEJMra050740
    • Moscona, A. Neuraminidase inhibitors for influenza. The New England journal of medicine 353, 1363-1373, doi: 10.1056/NEJMra050740 (2005).
    • (2005) The New England Journal of Medicine , vol.353 , pp. 1363-1373
    • Moscona, A.1
  • 42
    • 79251559935 scopus 로고    scopus 로고
    • Combination chemotherapy for influenza
    • doi: 10.3390/v2081510
    • Govorkova, E. A., & Webster, R. G. Combination chemotherapy for influenza. Viruses 2, 1510-1529, doi: 10.3390/v2081510 (2010).
    • (2010) Viruses , vol.2 , pp. 1510-1529
    • Govorkova, E.A.1    Webster, R.G.2
  • 43
    • 55849102109 scopus 로고    scopus 로고
    • Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice
    • doi: 10.1128/AAC.01579-07
    • Ilyushina, N. A., et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrobial agents and chemotherapy 52, 3889-3897, doi: 10.1128/AAC.01579-07 (2008).
    • (2008) Antimicrobial Agents and Chemotherapy , vol.52 , pp. 3889-3897
    • Ilyushina, N.A.1
  • 44
    • 84886683780 scopus 로고    scopus 로고
    • Synergistic combinations of favipiravir and oseltamivir against wild-Type pandemic and oseltamivir-resistant influenza A virus infections in mice
    • doi: 10.2217/fvl.13.98
    • Smee, D. F., Tarbet, E. B., Furuta, Y., Morrey, J. D., & Barnard, D. L. Synergistic combinations of favipiravir and oseltamivir against wild-Type pandemic and oseltamivir-resistant influenza A virus infections in mice. Future Virol 8, 1085-1094, doi: 10.2217/fvl.13.98 (2013).
    • (2013) Future Virol , vol.8 , pp. 1085-1094
    • Smee, D.F.1    Tarbet, E.B.2    Furuta, Y.3    Morrey, J.D.4    Barnard, D.L.5
  • 45
    • 84901975118 scopus 로고    scopus 로고
    • In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus
    • doi: 10.1007/s00705-013-1922-1
    • Tarbet, E. B., et al. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus. Arch Virol 159, 1279-1291, doi: 10.1007/s00705-013-1922-1 (2014).
    • (2014) Arch Virol , vol.159 , pp. 1279-1291
    • Tarbet, E.B.1
  • 46
    • 33847688459 scopus 로고    scopus 로고
    • Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice
    • doi: 10.1128/AAC.01051-06
    • Sidwell, R. W., et al. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrobial agents and chemotherapy 51, 845-851, doi: 10.1128/AAC.01051-06 (2007).
    • (2007) Antimicrobial Agents and Chemotherapy , vol.51 , pp. 845-851
    • Sidwell, R.W.1
  • 47
    • 84859053626 scopus 로고    scopus 로고
    • Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
    • doi: 10.1016/j.antiviral.2012.03.001
    • Tarbet, E. B., et al. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. Antiviral Res 94, 103-110, doi: 10.1016/j.antiviral.2012.03.001 (2012).
    • (2012) Antiviral Res , vol.94 , pp. 103-110
    • Tarbet, E.B.1
  • 48
    • 77955985167 scopus 로고    scopus 로고
    • A systematic review of side effects of nucleoside and nucleotide drugs used for treatment of chronic hepatitis B
    • doi: 10.1007/s11901-010-0039-1
    • Khungar, V., & Han, S H. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. Curr Hepat Rep 9, 75-90, Doi: 10.1007/s11901-010-0039-1 (2010).
    • (2010) Curr Hepat Rep , vol.9 , pp. 75-90
    • Khungar, V.1    Han, S.H.2
  • 49
    • 66149190942 scopus 로고    scopus 로고
    • Side effects of long-Term oral antiviral therapy for hepatitis B
    • doi: 10.1002/hep.22885
    • Fontana, R. J. Side effects of long-Term oral antiviral therapy for hepatitis B. Hepatology 49, S185-195, doi: 10.1002/hep.22885 (2009).
    • (2009) Hepatology , vol.49 , pp. S185-S195
    • Fontana, R.J.1
  • 50
    • 70449854577 scopus 로고    scopus 로고
    • Innate immune responses to influenza A H5N1: Friend or foe?
    • doi: 10.1016/j.it.2009.09.004
    • Peiris, J S., Cheung, C. Y., Leung, C. Y., & Nicholls, J. M. Innate immune responses to influenza A H5N1: friend or foe?. Trends Immunol 30, 574-584, doi: 10.1016/j.it.2009.09.004 (2009).
    • (2009) Trends Immunol , vol.30 , pp. 574-584
    • Peiris, J.S.1    Cheung, C.Y.2    Leung, C.Y.3    Nicholls, J.M.4
  • 51
    • 10744231351 scopus 로고    scopus 로고
    • Re-emergence of fatal human influenza A subtype H5N1 disease
    • doi: 10.1016/S0140-6736(04)15595-5
    • Peiris, J. S., et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619, doi: 10.1016/S0140-6736(04)15595-5 (2004).
    • (2004) Lancet , vol.363 , pp. 617-619
    • Peiris, J.S.1
  • 52
    • 0037038866 scopus 로고    scopus 로고
    • Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease?
    • Cheung, C. Y., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360, 1831-1837 (2002).
    • (2002) Lancet , vol.360 , pp. 1831-1837
    • Cheung, C.Y.1
  • 53
    • 43449131547 scopus 로고    scopus 로고
    • Pathology molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans
    • doi: 10.2353/ajpath.2008.070791
    • Korteweg, C., & Gu, J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172, 1155-1170, doi: 10.2353/ajpath.2008.070791 (2008).
    • (2008) Am J Pathol , vol.172 , pp. 1155-1170
    • Korteweg, C.1    Gu, J.2
  • 54
    • 84890378712 scopus 로고    scopus 로고
    • Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus
    • doi: 10.1016/j.ajpath.2013.10.004
    • Ogiwara, H., et al. Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus. Am J Pathol 184, 171-183, doi: 10.1016/j.ajpath.2013.10.004 (2014).
    • (2014) Am J Pathol , vol.184 , pp. 171-183
    • Ogiwara, H.1
  • 55
    • 84919794244 scopus 로고    scopus 로고
    • Characterization of susceptibility variants of influenza virus grown in the presence of T-705
    • Daikoku, T., Yoshida, Y., Okuda, T., & Shiraki, K. Characterization of susceptibility variants of influenza virus grown in the presence of T-705. Journal of pharmacological sciences 126, 281-284 (2014).
    • (2014) Journal of Pharmacological Sciences , vol.126 , pp. 281-284
    • Daikoku, T.1    Yoshida, Y.2    Okuda, T.3    Shiraki, K.4
  • 56
    • 84880006467 scopus 로고    scopus 로고
    • The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-Triphosphate towards influenza A virus polymerase
    • doi: 10.1371/journal. pone.0068347
    • Jin, Z., Smith, L. K., Rajwanshi, V. K., Kim, B., & Deval, J. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-Triphosphate towards influenza A virus polymerase. PloS one 8, e68347, doi: 10.1371/journal. pone.0068347 (2013).
    • (2013) PloS One , vol.8 , pp. e68347
    • Jin, Z.1    Smith, L.K.2    Rajwanshi, V.K.3    Kim, B.4    Deval, J.5
  • 57
    • 66149185685 scopus 로고    scopus 로고
    • Benefits and risks of combination therapy for hepatitis B
    • doi: 10.1002/hep.22921
    • Terrault, N. A. Benefits and risks of combination therapy for hepatitis B. Hepatology 49, S122-128, doi: 10.1002/hep.22921 (2009).
    • (2009) Hepatology , vol.49 , pp. S122-S128
    • Terrault, N.A.1
  • 58
    • 33745158157 scopus 로고
    • A simple method of estimating fifty per cent endpoint
    • Reed, L. J., & Muench, H. A simple method of estimating fifty per cent endpoint. American Journal of Hygine 27, 493-497 (1938).
    • (1938) American Journal of Hygine , vol.27 , pp. 493-497
    • Reed, L.J.1    Muench, H.2
  • 59
    • 84897133117 scopus 로고    scopus 로고
    • MOSAIK: A hash-based algorithm for accurate next-generation sequencing short-read mapping
    • doi: 10.1371/journal.pone.0090581
    • Lee, W. P., et al. MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping. PloS one 9, e90581, doi: 10.1371/journal.pone.0090581 (2014).
    • (2014) PloS One , vol.9 , pp. e90581
    • Lee, W.P.1
  • 60
    • 84870422798 scopus 로고    scopus 로고
    • Qualimap: Evaluating next-generation sequencing alignment data
    • doi: 10.1093/bioinformatics/bts503
    • Garcia-Alcalde, F., et al. Qualimap: evaluating next-generation sequencing alignment data. Bioinformatics 28, 2678-2679, doi: 10.1093/bioinformatics/bts503 (2012).
    • (2012) Bioinformatics , vol.28 , pp. 2678-2679
    • Garcia-Alcalde, F.1
  • 61
    • 84884893391 scopus 로고    scopus 로고
    • V-Phaser 2: Variant inference for viral populations
    • doi: 10.1186/1471-2164-14-674
    • Yang, X., Charlebois, P., Macalalad, A., Henn, M. R., & Zody, M. C. V-Phaser 2: variant inference for viral populations. BMC Genomics 14, 674, doi: 10.1186/1471-2164-14-674 (2013).
    • (2013) BMC Genomics , vol.14 , pp. 674
    • Yang, X.1    Charlebois, P.2    Macalalad, A.3    Henn, M.R.4    Zody, M.C.5
  • 62
    • 84971316039 scopus 로고    scopus 로고
    • DiversiTools: A program to analyze the intra-host variation from their high-Throughput reads
    • URL
    • Orton, R., & Hughes, J. diversiTools: A program to analyze the intra-host variation from their high-Throughput reads. diversiTools, Glasgow, Scotland. URL http://josephhughes.github.io/btctools/(2015).
    • (2015) DiversiTools, Glasgow, Scotland
    • Orton, R.1    Hughes, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.